Sanofi
SNY
547 hedge funds and large institutions have $8.2B invested in Sanofi in 2020 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 185 increasing their positions, 181 reducing their positions, and 57 closing their positions.
630% more call options, than puts
Call options by funds: $86.7M | Put options by funds: $11.9M
40% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 57
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
3% more funds holding
Funds holding: 531 → 547 (+16)
2% more repeat investments, than reductions
Existing positions increased: 185 | Existing positions reduced: 181
0.62% more ownership
Funds ownership: 14.31% → 14.93% (+0.62%)
9% less capital invested
Capital invested by funds: $9.01B → $8.2B (-$807M)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$354M |
| 2 |
BlackRock
New York
|
+$222M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$141M |
| 4 |
JP Morgan Chase
New York
|
+$89.8M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$57.1M |
Top Sellers
SNY Hedge Fund Activity: Q1 2020 in Review
547 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2020, worth a combined $8.2B — down 9% from $9.01B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new SNY positions and 57 closed out — a net gain of 23 holders — while 185 added to existing stakes and 181 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $354M. The largest seller was Dodge & Cox, cutting an estimated $516M.
- 547 institutional investors held Sanofi (SNY) as of Q1 2020, up from 531 in Q4 2019.
- Funds reported $8.2B of Sanofi stock for Q1 2020, down 9% quarter-over-quarter.
- 80 funds opened new Sanofi positions in Q1 2020 and 57 closed out, a net change of +23 holders.
- The largest Sanofi buyer in Q1 2020 was Fidelity Investments, an estimated $354M added.
- The largest Sanofi seller in Q1 2020 was Dodge & Cox, an estimated $516M sold.
Based on aggregated 13F filings for Q1 2020.